Immune responses to all ErbB family receptors detectable in serum of cancer patients
- 11 February 1999
- journal article
- Published by Springer Nature in Oncogene
- Vol. 18 (6), 1267-1275
- https://doi.org/10.1038/sj.onc.1202442
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 32 references indexed in Scilit:
- Selective Cleavage of the Heregulin Receptor ErbB-4 by Protein Kinase C ActivationJournal of Biological Chemistry, 1996
- All ErbB Receptors Other Than the Epidermal Growth Factor Receptor Are Endocytosis ImpairedJournal of Biological Chemistry, 1996
- Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines.The Journal of Experimental Medicine, 1995
- The biology of erbB-2/nue/HER-2 and its role in cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1994
- A neu acquaintance for ErbB3 and ErbB4: A role for receptor heterodimerization in growth signalingCell, 1994
- Modulation of mouse preimplantation development by epidermal growth factor receptor antibodies, antisense RNA, and deoxyoligonucleotidesDevelopmental Genetics, 1993
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cellsCell, 1987
- Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptorNature, 1986
- Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cellsNature, 1984